SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001683168-23-008407
Filing Date
2023-11-22
Accepted
2023-11-21 21:11:38
Documents
4
Effectiveness Date
2023-11-22

Document Format Files

Seq Description Document Type Size
1 S-8 cns_s8.htm S-8 35815
2 CONSENT cns_ex5.htm EX-5 6808
3 CONSENT cns_ex2301.htm EX-23.1 2520
4 CALCULATION OF FILING FEE TABLES cns_ex107.htm EX-FILING FEES 12982
  Complete submission text file 0001683168-23-008407.txt   59140
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

IRS No.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-275699 | Film No.: 231429761
SIC: 2834 Pharmaceutical Preparations